A first report of right-hemicolectomy for ascending colon cancer in Japan with the da Vinci SP surgical robot system.

IF 0.7 Q4 SURGERY

Surgical Case Reports Pub Date : 2024-05-21 DOI:10.1186/s40792-024-01922-w

Ai Noda, Koichi Okuya, Emi Akizuki, Masaaki Miyo, Masayuki Ishii, Ryo Miura, Momoko Ichihara, Maho Toyota, Tatsuya Ito, Tadashi Ogawa, Akina Kimura, Ichiro Takemasa

{"title":"A first report of right-hemicolectomy for ascending colon cancer in Japan with the da Vinci SP surgical robot system.","authors":"Ai Noda, Koichi Okuya, Emi Akizuki, Masaaki Miyo, Masayuki Ishii, Ryo Miura, Momoko Ichihara, Maho Toyota, Tatsuya Ito, Tadashi Ogawa, Akina Kimura, Ichiro Takemasa","doi":"10.1186/s40792-024-01922-w","DOIUrl":null,"url":null,"abstract":"Background: The da Vinci SP robotic surgical system received regulatory approval for use in colorectal cancer surgery in Japan in April 2023. Given the advantages of the precision of a robot and the postoperative cosmesis of single-site surgery, the system is expected to be further utilized for minimally invasive surgeries, in addition to the curative and safety-assured laparoscopic technique.Case presentation: A 73-year-old man presented at our hospital with positive fecal occult blood. He was diagnosed with cT2N0M0 (Stage I) ascending colon cancer and underwent a right hemicolectomy, which was performed with the da Vinci SP system. The operation was performed safely, and the patient was discharged without complications. Pathology findings showed that complete mesocolic excision was achieved.Conclusions: Herein, we report the first colorectal cancer surgery performed using the da Vinci SP system in Japan. The use of this robotic surgical system with access forms for right hemicolectomy is safe and oncologically appropriate.","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109069/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40792-024-01922-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The da Vinci SP robotic surgical system received regulatory approval for use in colorectal cancer surgery in Japan in April 2023. Given the advantages of the precision of a robot and the postoperative cosmesis of single-site surgery, the system is expected to be further utilized for minimally invasive surgeries, in addition to the curative and safety-assured laparoscopic technique.

Case presentation: A 73-year-old man presented at our hospital with positive fecal occult blood. He was diagnosed with cT2N0M0 (Stage I) ascending colon cancer and underwent a right hemicolectomy, which was performed with the da Vinci SP system. The operation was performed safely, and the patient was discharged without complications. Pathology findings showed that complete mesocolic excision was achieved.

Conclusions: Herein, we report the first colorectal cancer surgery performed using the da Vinci SP system in Japan. The use of this robotic surgical system with access forms for right hemicolectomy is safe and oncologically appropriate.

查看原文本刊更多论文

日本首例利用达芬奇 SP 手术机器人系统对升结肠癌进行右半结肠切除术的报告。

背景：达芬奇 SP 机器人手术系统于 2023 年 4 月获得日本监管部门批准，可用于结直肠癌手术。鉴于机器人的精确性和单部位手术的术后美观性等优势，该系统有望在治愈性和安全性有保障的腹腔镜技术之外，进一步用于微创手术：一名 73 岁的男性因大便潜血阳性来我院就诊。他被确诊为 cT2N0M0（I 期）升结肠癌，并接受了右半结肠切除术，手术采用达芬奇 SP 系统。手术安全完成，患者无并发症出院。病理结果显示结肠系膜完全切除：在此，我们报告了日本首例使用达芬奇 SP 系统进行的结直肠癌手术。结论：我们在此报告了日本首例使用达芬奇 SP 系统进行的结直肠癌手术，该机器人手术系统的入路形式可用于右半结肠切除术，既安全又适合肿瘤学。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgical Case Reports SURGERY-

自引率

0.00%

发文量

218

审稿时长

13 weeks

文献相关原料

公司名称	产品信息	采购帮参考价格